JOSH'S STORY
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreRecurrent medulloblastoma (MB) is nearly universally fatal, and surgery at the time of recurrence is associated with significant morbidity and discomfort1. Presently, novel agents are tested in children with recurrent MB based on the unsubstantiated assumption that a heavenly treated MB tumour at recurrence is highly similar to the tumour at diagnosis. However, a recent genomic study2 demonstrated that MB presents a striking evolutionary plasticity over time showing that only 11.8% of genetic alterations identified at diagnosis are also present in the recurrent tumour. This demonstrates a substantial genetic divergence at recurrence highlighting the need of better cellular systems to model the recurrent disease.
Grant Award – Kidscan Placement Student (2017-2018)
Funding Award – £2,000
Funding Awarded To – Dr Gianpiero Di Leva
Research Location – University of Salford
Lead Researcher – Dr Gianpiero Di Leva
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreWhat a whopper of a night - Friday 20th May, our ambassador Isla's mum Jill and family hosted...
Read MoreWe want to say a huge thank you to Lee Mossop, former Captain of RFL Salford Red...
Read More